258 related articles for article (PubMed ID: 30559134)
1. Isavuconazole in the Treatment of Coccidioidal Meningitis.
Heidari A; Quinlan M; Benjamin DJ; Laurence B; Mu A; Ngai T; Hoffman WJ; Cohen SH; McHardy I; Johnson R; Thompson GR
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559134
[TBL] [Abstract][Full Text] [Related]
2. Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis.
Naeem F; Laningham F; Kuzmic B; Clerkin P; McCarty J
Pediatr Infect Dis J; 2021 Mar; 40(3):e128-e131. PubMed ID: 33315746
[TBL] [Abstract][Full Text] [Related]
3. Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring.
Davis MR; Chang S; Gaynor P; McCreary EK; Allyn P
Med Mycol; 2021 Sep; 59(9):939-942. PubMed ID: 34143187
[TBL] [Abstract][Full Text] [Related]
4. Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.
Antony SJ; Jurczyk P; Brumble L
J Natl Med Assoc; 2006 Jun; 98(6):940-2. PubMed ID: 16775917
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of coccidioidal meningitis with voriconazole.
Cortez KJ; Walsh TJ; Bennett JE
Clin Infect Dis; 2003 Jun; 36(12):1619-22. PubMed ID: 12802765
[TBL] [Abstract][Full Text] [Related]
6. Lack of Toxicity With Long-term Isavuconazole Use in Patients With Hematologic Malignancy.
DiPippo AJ; Kontoyiannis DP
Clin Infect Dis; 2019 Oct; 69(9):1624-1627. PubMed ID: 30861066
[TBL] [Abstract][Full Text] [Related]
7. Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis.
Heidari A; Sharma R; Shakir Q; Shah M; Clement J; Donnelley MA; Reynolds T; Trigg K; Jolliff J; Kuran R; Johnson R; Thompson GR
Clin Infect Dis; 2023 Jun; 76(12):2196-2199. PubMed ID: 36905151
[TBL] [Abstract][Full Text] [Related]
8. Posaconazole for chronic refractory coccidioidal meningitis.
Schein R; Homans J; Larsen RA; Neely M
Clin Infect Dis; 2011 Dec; 53(12):1252-4. PubMed ID: 21987729
[TBL] [Abstract][Full Text] [Related]
9. Comparison of amphotericin B lipid complex with amphotericin B and SCH 39304 in the treatment of murine coccidioidal meningitis.
Allendoerfer R; Yates RR; Sun SH; Graybill JR
J Med Vet Mycol; 1992; 30(5):377-84. PubMed ID: 1469539
[TBL] [Abstract][Full Text] [Related]
10. Real-world use-Isavuconazole at a large academic medical center.
Hassouna H; Athans V; Brizendine KD
Mycoses; 2019 Jun; 62(6):534-541. PubMed ID: 30851214
[TBL] [Abstract][Full Text] [Related]
11. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
Miceli MH; Kauffman CA
Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
[TBL] [Abstract][Full Text] [Related]
12. Isavuconazole: a new extended spectrum triazole for invasive mold diseases.
Ananda-Rajah MR; Kontoyiannis D
Future Microbiol; 2015; 10(5):693-708. PubMed ID: 26000646
[TBL] [Abstract][Full Text] [Related]
13. Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis.
Stewart ER; Eldridge ML; McHardy I; Cohen SH; Thompson GR
Mycopathologia; 2018 Jun; 183(3):619-622. PubMed ID: 29340909
[TBL] [Abstract][Full Text] [Related]
14. Successful kidney transplantation after coccidioidal meningitis.
Kokseng SL; Blair JE
Transpl Infect Dis; 2011 Jun; 13(3):285-9. PubMed ID: 21040281
[TBL] [Abstract][Full Text] [Related]
15. Coccidioidal meningitis in non-AIDS patients. A case series at a Mexican neurological referral center.
Cárdenas G; Aristizábal S; Salinas C; Delgado-Hernández R; Angeles-Morales V; Soto-Hernández J; Castañón-Olivares LR; Hernández F
Clin Neurol Neurosurg; 2020 Sep; 196():106011. PubMed ID: 32593044
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole treatment of coccidioidal meningitis in children: two case reports and a review of the literature.
Saitoh A; Homans J; Kovacs A
Pediatr Infect Dis J; 2000 Dec; 19(12):1204-8. PubMed ID: 11144385
[No Abstract] [Full Text] [Related]
17. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Marty FM; Cornely OA; Mullane KM; Ostrosky-Zeichner L; Maher RM; Croos-Dabrera R; Lu Q; Lademacher C; Oren I; Schmitt-Hoffmann AH; Giladi M; Rahav G; Perfect JR
Mycoses; 2018 Jul; 61(7):485-497. PubMed ID: 29611227
[TBL] [Abstract][Full Text] [Related]
18. Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis.
Cheng MP; Orejas JL; Arbona-Haddad E; Bold TD; Solomon IH; Chen K; Pandit A; Kusztos AE; Cummins KC; Liakos A; Marty FM; Koo S; Hammond SP
Mycoses; 2020 Jan; 63(1):58-64. PubMed ID: 31587405
[TBL] [Abstract][Full Text] [Related]
19. Coccidioidomycosis: Recent Updates.
Twarog M; Thompson GR
Semin Respir Crit Care Med; 2015 Oct; 36(5):746-55. PubMed ID: 26398540
[TBL] [Abstract][Full Text] [Related]
20. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
